Abstract
The combination of etoposide and cis-platinum was evaluated in the treatment of advanced ovarian cancer. Of 13 treated patients, 4 demonstrated complete clinical responses and 3 demonstrated partial clinical responses. The mean progression free interval was 14+ months for the complete responders and 8.3+ months for the partial responders. The 100 mg/m2 dose of etoposide appears to be critical in attaining response. This etoposide and cis-platinum combination appears to be effective as a salvage regimen in ovarian carcicnoma.
Original language | English |
---|---|
Pages (from-to) | 350-356 |
Number of pages | 7 |
Journal | Gynecologic Oncology |
Volume | 27 |
Issue number | 3 |
DOIs | |
State | Published - Jul 1987 |